使い捨て内視鏡の世界市場 - 市場考察、競合情勢、市場予測（2032年）

世界の使い捨て内視鏡の市場規模は、2024年に26億5,844万米ドルであり、2032年までに57億4,875万米ドルに達すると予測され、2025年～2032年の予測期間にCAGRで10.19%の成長が見込まれます。医療環境における二次汚染や感染の増加により、使い捨て内視鏡のような、再処理が不要で感染リスクを低減できる、より安全な代替品への需要が高まっています。また、消化器疾患、呼吸器疾患、泌尿器疾患などの慢性疾患の増加により、診断や治療を目的とした内視鏡手技が増加しています。さらに、イメージング、携行性、AI統合の進歩を含む継続的な製品開発活動は、機器の性能と使いやすさを向上させています。これらの要因が、2025年～2032年の予測期間に使い捨て内視鏡の世界市場全体の成長を大きく後押ししています。

使い捨て内視鏡の市場力学

世界保健機関（WHO）（2022）のデータによると、急性期病院に入院した患者100人あたり、高所得国では約7人、中低所得国では約15人が、入院中に少なくとも1回の医療関連感染（HAI）を発症しています。さらに、同レポートでは、抗生物質の効かない医療関連感染症が世界で毎年約1億3,600万件発生していると推定しています。

再使用可能な内視鏡は、再処理が行われているにもかかわらず、クロストリジオイデスディフィシル、緑膿菌、MRSA、VRE、CREのような薬剤耐性菌などの感染症を伝播する重大なリスクをもたらし続けています。対照的に、使い捨て内視鏡は無菌で使い捨てのソリューションであり、消毒の失敗のリスクを排除します。そのため、集中治療室（ICU）や救急部などのリスクの高い環境に特に適しています。それゆえ、感染管理の向上と、より安全で効率的な臨床実践へのニーズが、使い捨て内視鏡需要の拡大を推進しています。

さらに、呼吸器、消化器、泌尿器疾患の有病率の増加が使い捨て内視鏡市場をさらに牽引しています。World Gastroenterology Organization（2023）によると、全世界で女性の約49%、男性の36.6%が少なくとも1つの機能性胃腸障害の基準を満たしています。同様に、Urology Foundation（2023）のデータによると、英国ではおよそ2人に1人が泌尿器疾患を経験しています。このような罹患率の上昇は、診断手技や治療手技の需要の増加に寄与しており、使い捨て内視鏡ソリューションの必要性を高めています。

再使用可能な内視鏡は効果的ですが、複雑で時間とコストのかかる再処理プロトコルが必要であり、交差汚染のリスクもあります。外来手術センターや救急外来での内視鏡手技の増加に伴い、使い捨て内視鏡は実用的な代替手段を提供します。使い捨て内視鏡は、感染リスクを低減し、所要時間を短縮し、患者処理能力を向上させます。

さらに、業界の主要企業による継続的な製品開発活動が市場の拡大を支えています。例えば2022年5月、Ambuは無菌のシングルユース気管支内視鏡製品であるAmbu（R）aScope（TM）5 Bronchoに対する欧州規制当局の承認を取得しました。

したがって、上記の要因が2025年～2032年の予測期間に使い捨て内視鏡市場の成長を総体的に促進する見込みです。

しかし、このような利点にもかかわらず、特定の制限が市場成長の妨げになる可能性があります。使い捨て内視鏡はシングルユース機器であるため、医療廃棄物の原因となり、環境と持続可能性への懸念が高まります。さらに、複雑な手技への適合性に限界があるため、一部の臨床環境での採用が制限される可能性があり、より広い市場拡大に対する主な抑制要因となっています。

北米が使い捨て内視鏡市場全体を独占する見込み

北米は、医療関連感染（HAI）の罹患率の上昇、泌尿器疾患や消化器疾患のような慢性疾患の有病率の増加、医療技術の継続的な進歩など、複数の要因によって2024年に世界の使い捨て内視鏡市場を主導すると予測されています。

当レポートでは、世界の使い捨て内視鏡市場について調査分析し、市場規模と予測、過去3年の製品/サービス開発、市場の主要企業、利用可能な機会などの情報を提供しています。

目次

第1章 使い捨て内視鏡市場レポートのイントロダクション

第2章 使い捨て内視鏡市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 使い捨て内視鏡市場の主な要因の分析

• 使い捨て内視鏡市場の促進要因
• 使い捨て内視鏡市場の抑制要因と課題
• 使い捨て内視鏡市場の機会

第6章 使い捨て内視鏡市場：ポーターのファイブフォース分析

第7章 使い捨て内視鏡市場の評価

• 製品別
  • 気管支鏡
  • 胃カメラ
  • 十二指腸内視鏡
  • 喉頭鏡
  • その他
• 用途別
  • 呼吸器科
  • 消化器科
  • 泌尿器科
  • 耳鼻咽喉科
• エンドユーザー別
  • 病院・診療所
  • 外来手術センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 使い捨て内視鏡市場の企業と製品のプロファイル

• Olympus Corporation
• Boston Scientific Corporation
• Ambu Inc.
• ProSurg Inc.
• Baxter
• Teleflex Incorporated
• Flexicare Medical Limited
• AUG Medical
• NeoScope Inc
• Xenocor Inc.
• 3NT Medical
• Corinth MedTech, Inc.
• PENTAX Medical
• Daichuan medical
• Omnivision
• Verathon

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Disposable Endoscopes Market in Global (2022-2033)
• Table 3: Disposable Endoscopes Market in Global by Product (2022-2033)
• Table 4: Disposable Endoscopes Market in Global by Application (2022-2033)
• Table 5: Disposable Endoscopes Market in Global by End-User (2022-2033)
• Table 6: Disposable Endoscopes Market in Global by Geography (2022-2033)
• Table 7: Disposable Endoscopes Market in North America (2022-2033)
• Table 8: Disposable Endoscopes Market in the United States (2022-2033)
• Table 9: Disposable Endoscopes Market in Canada (2022-2033)
• Table 10: Disposable Endoscopes Market in Mexico (2022-2033)
• Table 11: Disposable Endoscopes Market in Europe (2022-2033)
• Table 12: Disposable Endoscopes Market in France (2022-2033)
• Table 13: Disposable Endoscopes Market in Germany (2022-2033)
• Table 14: Disposable Endoscopes Market in United Kingdom (2022-2033)
• Table 15: Disposable Endoscopes Market in Italy (2022-2033)
• Table 16: Disposable Endoscopes Market in Spain (2022-2033)
• Table 17: Disposable Endoscopes Market in Rest of Europe (2022-2033)
• Table 18: Disposable Endoscopes Market in Asia-Pacific (2022-2033)
• Table 19: Disposable Endoscopes Market in China (2022-2033)
• Table 20: Disposable Endoscopes Market in Japan (2022-2033)
• Table 21: Disposable Endoscopes Market in India (2022-2033)
• Table 22: Disposable Endoscopes Market in Australia (2022-2033)
• Table 23: Disposable Endoscopes Market in South Korea (2022-2033)
• Table 24: Disposable Endoscopes Market in Rest of Asia-Pacific (2022-2033)
• Table 25: Disposable Endoscopes Market in Rest of the World (2022-2033)
• Table 26: Disposable Endoscopes Market in the Middle East (2022-2033)
• Table 27: Disposable Endoscopes Market in Africa (2022-2033)
• Table 28: Disposable Endoscopes Market in South America (2022-2033)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Disposable Endoscopes Market in Global (2022-2033)
• Figure 3: Disposable Endoscopes Market in Global by Product (2022-2033)
• Figure 4: Disposable Endoscopes Market in Global by Application (2022-2033)
• Figure 5: Disposable Endoscopes Market in Global by End-User (2022-2033)
• Figure 6: Disposable Endoscopes Market in Global by Geography (2022-2033)
• Figure 7: Disposable Endoscopes Market in North America (2022-2033)
• Figure 8: Disposable Endoscopes Market in the United States (2022-2033)
• Figure 9: Disposable Endoscopes Market in Canada (2022-2033)
• Figure 10: Disposable Endoscopes Market in Mexico (2022-2033)
• Figure 11: Disposable Endoscopes Market in Europe (2022-2033)
• Figure 12: Disposable Endoscopes Market in France (2022-2033)
• Figure 13: Disposable Endoscopes Market in Germany (2022-2033)
• Figure 14: Disposable Endoscopes Market in United Kingdom (2022-2033)
• Figure 15: Disposable Endoscopes Market in Italy (2022-2033)
• Figure 16: Disposable Endoscopes Market in Spain (2022-2033)
• Figure 17: Disposable Endoscopes Market in Rest of Europe (2022-2033)
• Figure 18: Disposable Endoscopes Market in Asia-Pacific (2022-2033)
• Figure 19: Disposable Endoscopes Market in China (2022-2033)
• Figure 20: Disposable Endoscopes Market in Japan (2022-2033)
• Figure 21: Disposable Endoscopes Market in India (2022-2033)
• Figure 22: Disposable Endoscopes Market in Australia (2022-2033)
• Figure 23: Disposable Endoscopes Market in South Korea (2022-2033)
• Figure 24: Disposable Endoscopes Market in Rest of Asia-Pacific (2022-2033)
• Figure 25: Disposable Endoscopes Market in Rest of the World (2022-2033)
• Figure 26: Disposable Endoscopes Market in the Middle East (2022-2033)
• Figure 27: Disposable Endoscopes Market in Africa (2022-2033)
• Figure 28: Disposable Endoscopes Market in South America (2022-2033)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing instances of cross-contamination and infections, increasing prevalence of chronic conditions, and rising product developmental activities globally.

The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032. The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

Disposable Endoscopes Market Dynamics:

According to data from the World Health Organization (2022), for every 100 patients admitted to acute-care hospitals, approximately 7 in high-income countries and 15 in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay. Furthermore, the same report estimates that around 136 million cases of healthcare-associated, antibiotic-resistant infections occur globally each year.

Reusable endoscopes, despite undergoing reprocessing, continue to pose a significant risk of transmitting infections such as Clostridioides difficile, Pseudomonas aeruginosa, and drug-resistant organisms like MRSA, VRE, and CRE. In contrast, disposable endoscopes offer a sterile, single-use solution that eliminates the risk of disinfection failures. This makes them particularly suitable for high-risk environments such as intensive care units (ICUs) and emergency departments. Consequently, the need for improved infection control and safer, more efficient clinical practices is fueling the growing demand for disposable endoscopes.

In addition, the increasing prevalence of respiratory, gastrointestinal, and urological conditions is further driving the disposable endoscope market. According to the World Gastroenterology Organization (2023), approximately 49% of females and 36.6% of males globally meet the criteria for at least one functional gastrointestinal disorder. Similarly, data from the Urology Foundation (2023) indicate that around one in two individuals in the United Kingdom experiences a urological condition. These rising disease rates are contributing to increased demand for diagnostic and therapeutic procedures, thereby boosting the need for disposable endoscopic solutions.

While reusable endoscopes are effective, they require complex, time-consuming, and costly reprocessing protocols, which also carry a risk of cross-contamination. With a growing number of endoscopic procedures being performed in outpatient settings, ambulatory surgical centers, and emergency departments, disposable endoscopes offer a practical alternative. They reduce infection risk, shorten turnaround times, and enhance patient throughput.

Moreover, ongoing product development efforts by key industry players are supporting market expansion. For example, in May 2022, Ambu received European regulatory approval for its Ambu(R) aScope(TM) 5 Broncho, a line of sterile, single-use bronchoscopes.

Therefore, the factors outlined above are expected to collectively drive the growth of the disposable endoscopes market during the forecast period from 2025 to 2032.

However, despite these advantages, certain limitations could hinder market growth. As single-use devices, disposable endoscopes contribute to medical waste, raising environmental and sustainability concerns. Additionally, their limited suitability for complex procedures may restrict adoption in some clinical settings, serving as key constraints on broader market expansion.

Disposable Endoscopes Market Segment Analysis:

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the products segment of disposable endoscopes, the bronchoscopes category is expected to have a significant revenue share in the year 2024. This can be ascribed to their advantages, such as the use of bronchoscopes in the diagnosis and treatment of tumors and bronchial cancers, airway blockage (obstruction), narrowed areas in the airways, and interstitial pulmonary diseases, among others.

Another key aspect contributing in the growing demand for bronchoscopes is that it also comprises of increased detection and improved access, reaching to the most distant regions of the lungs, earlier diagnosis of lung tumors, better treatment decisions, reduced risk associated with complications, and eliminating the risk associated with invasive surgeries, all of the advantages possible due to the presence of navigational bronchoscopy.

Given the advantages associated with navigational bronchoscopy, there has been increasing acceptance among end users, which in turn has led to a rise in the number of new product launches in the market. For example, in April 2023, Verathon, a leading global medical device company, announced the launch of the BFlex(TM) 2, the next generation of its single-use bronchoscope portfolio. The upgraded BFlex 2 series features four scope sizes and incorporates enhanced capabilities aimed at helping clinicians deliver improved care for both adult and pediatric patients across various hospital settings.

Therefore, driven by these advancements and growing clinical adoption, the bronchoscopes segment is anticipated to experience significant growth, thereby contributing substantially to the overall expansion of the disposable endoscopes market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall disposable endoscopes market:

North America is expected to lead the global disposable endoscopes market in 2024, driven by several key factors, including the rising incidence of healthcare-associated infections (HAIs), the growing prevalence of chronic conditions such as urological and gastrointestinal disorders, and continued advancements in healthcare technology.

One of the primary drivers in the region is the increasing risk of cross-contamination associated with reusable endoscopes. According to data from the Centers for Disease Control and Prevention (CDC, 2024), approximately 1 in 31 hospital patients in the United States acquires at least one healthcare-associated infection. Similarly, recent data from the Provincial Infection Control Network of British Columbia (2025) reported that in Canada, 1 in 9 hospital patients contract an HAI, with over 220,000 such cases occurring annually. These statistics underscore the growing threat of infection in clinical settings, especially where reusable devices are used. Disposable endoscopes, being sterile and single-use, eliminate the risk of cross-contamination and are increasingly preferred in high-risk environments such as ICUs and emergency departments.

Additionally, technological innovations and regulatory support are strengthening the regional market. North America has witnessed a surge in product development and regulatory approvals, supported by a well-established healthcare infrastructure and the strong presence of key medical device companies. These conditions create a favorable ecosystem for market expansion.

For example, in May 2024, Olympus Corporation announced the launch of the DVM-B2 Digital Video Monitor, an integrated video processor and monitor specifically designed for use with single-use endoscopes. This system supports applications in bronchoscopy and ENT procedures and is compatible with Olympus's H-SteriScope(TM) Single-use Flexible Bronchoscopes and E-SteriScope(TM) Single-use Flexible Rhinolaryngoscopes. The device, manufactured by Hunan Vathin Medical Instruments Co., Ltd., is distributed exclusively by Olympus America, Inc., further reinforcing the company's commitment to advancing disposable endoscopy solutions in the region.

Moreover, increased awareness of infection control, favorable reimbursement frameworks, and ongoing partnerships and commercialization strategies among major industry players are expected to accelerate market growth further.

In conclusion, the convergence of rising HAI rates, technological innovation, growing demand for safer diagnostic tools, and strong regional healthcare investment is expected to make North America a dominant force in the disposable endoscopes market during the forecast period from 2025 to 2032.

Disposable Endoscopes Market key players:

Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

Recent Developmental Activities in the Disposable Endoscopes Market:

• In September 2023, Olympus Corporation launched the Vathin E-SteriScope single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures.
• In April 2023, Verathon, a global leader in airway management solutions, unveiled the GlideScope(R) Spectrum(TM) QC featuring QuickConnect(TM) technology. This extensive lineup of single-use video laryngoscopes showcases a magnetic connector coupled with improvements in image quality, designed to support rapid and effective airway management.
• In November 2022, PROACT Medical launched a new range of gas sampling lines along with their new line of single-use laryngoscopes to improve patient care in the European market.

Key takeaways from the disposable endoscopes market report study:

• Market size analysis for current disposable endoscopes market size (2024), and market forecast over 8 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the disposable endoscopes market
• Various opportunities available for the other competitors in the disposable endoscopes market space
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current disposable endoscopes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the disposable endoscopes market growth in the future?

Target audience who can benefit from this disposable endoscopes market report study:

• Disposable endoscopes product providers
• Research organizations and consulting companies
• Disposable endoscopes-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in disposable endoscopes
• Various end-users who want to know more about the disposable endoscopes market and the latest developments in the disposable endoscopes market

Frequently Asked Questions for the Disposable Endoscopes Market:

1. What are disposable endoscopes?

• The disposable endoscopes, also known as single-use endoscopes, are medical devices designed to perform minimally invasive diagnostic and therapeutic procedures within the body. Unlike reusable endoscopes, they are discarded after a single use, eliminating the need for sterilization and reprocessing.

2. What is the market for disposable endoscopes?

• The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032.

3. What are the drivers for the disposable endoscopes market?

• The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

4. Who are the key players operating in the disposable endoscopes market?

• Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

5. Which region has the highest share in the disposable endoscopes market?

• Among all the regions, North America is expected to dominate the disposable endoscopes market in the year 2024. This can be attributed to several factors, such as rising instances of cross-contamination and chronic conditions such as urological and gastrointestinal disorders. Additionally, the enhanced technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments are other major factors that are expected to drive the market for disposable endoscopes during the forecast period from 2025 to 2032.

Table of Contents

1. Disposable Endoscopes Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Disposable Endoscopes Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Disposable Endoscopes Market Key Factors Analysis

• 5.1. Disposable Endoscopes Market Drivers
  • 5.1.1. Increasing instances of cross-contamination and infections
  • 5.1.2. Increasing instances of chronic conditions
  • 5.1.3. Rising product development activities globally
• 5.2. Disposable Endoscopes Market Restraints and Challenges
  • 5.2.1. Raising concerns about the environmental impact
  • 5.2.2. Limitations associated with devices
  • 5.2.3. Stringent regulations for some of the single-use endoscopes
• 5.3. Disposable Endoscopes Market Opportunities
  • 5.3.1. Integration with imaging and navigation technologies

6. Disposable Endoscopes Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Disposable Endoscopes Market Assessment

• 7.1. By Product
  • 7.1.1. Bronchoscopes
  • 7.1.2. Gastroscopes
  • 7.1.3. Dudenoscopes
  • 7.1.4. Laryngoscopes
  • 7.1.5. Others
• 7.2. By Application
  • 7.2.1. Pulmonology
  • 7.2.2. Gastroenterology
  • 7.2.3. Urology
  • 7.2.4. ENT
  • 7.2.5. Others
• 7.3. By End-User
  • 7.3.1. Hospitals & Clinics
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.1.2. Canada Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.1.3. Mexico Disposable Endoscopes Market Size in USD million (2022-2033)
  • 7.4.2. Europe
    • 7.4.2.1. France Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.2.2. Germany Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.2.3. United Kingdom Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.2.4. Italy Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.2.5. Spain Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.2.6. Rest of Europe Disposable Endoscopes Market Size in USD million (2022-2033)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.3.2. Japan Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.3.3. India Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.3.4. Australia Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.3.5. South Korea Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.3.6. Rest of Asia-Pacific Disposable Endoscopes Market Size in USD million (2022-2033)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.4.2. Africa Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.4.3. South America Disposable Endoscopes Market Size in USD million (2022-2033)

8. Disposable Endoscopes Market Company and Product Profiles

• 8.1. Olympus Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Boston Scientific Corporation
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Ambu Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. ProSurg Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Baxter
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Teleflex Incorporated
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Flexicare Medical Limited
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. AUG Medical
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. NeoScope Inc
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Xenocor Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. 3NT Medical
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Corinth MedTech, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. PENTAX Medical
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Daichuan medical
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Omnivision
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Verathon
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us